Clinical study
ACTIVE2
Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)
| Status | Withdrawn |
|---|---|
| Type | Trial |
| Countries | United States |
| Conditions studied | Prosthetic Joint Infection |
| Study years | 2023–2027 (estimated) |
| Entry review | 2026-10-03 |
Participation
Check the study record or contact the study team for current recruitment and eligibility.
Study eligibility
Inclusion Criteria: * Males or females ≥18 years of age * Recurrent PJI of the knee or hip * Female patients of childbearing potential who agree to use contraception. * Confirmed phage match * No anticipated need for long-term antibiotics Exclusion Criteria: * Soft tissue defect requiring reconstruction * Hardware misalignment * Additional orthopedic hardware in connection with the infected prosthesis * Active infection (other than PJI) requiring long term IV antibiotics * Unable to tolerate SAT * Septic shock or hemodynamic instability * Stage 4 or greater chronic kidney disease * Liver disease * Decompensated heart failure * Positive drug screen * Receiving chemotherapy * Immunocompromised * Treatment with antiviral medication within 2 weeks prior to randomization * Currently participating in another clinical trial * Known phage allergy * Pregnant/ breast feeding * Lack of capacity to consent
Study description
This is a study designed to evaluate bacteriophage therapy in patients with chronic prosthetic joint infections.
Study registrations
| ClinicalTrials.gov | NCT05269134 |
|---|
Recorded study locations (10)
Locations listed in the study record; this does not confirm current recruitment or treatment outside the study. A site label may be older than the overall study status.
University of California San Diego Medical Center
San Diego, California, United States
Recorded site status: Not separately listed. Study location source ↗
Hartford Health Care Bone & Joint Insitute
Hartford, Connecticut, United States
Recorded site status: Not separately listed. Study location source ↗
Snake River Research
Idaho Falls, Idaho, United States
Recorded site status: Not separately listed. Study location source ↗
University of Maryland Medical Center
Baltimore, Maryland, United States
Recorded site status: Not separately listed. Study location source ↗
Sinai Hospital of Baltimore
Baltimore, Maryland, United States
Recorded site status: Not separately listed. Study location source ↗
Brigham & Women's Hospital
Boston, Massachusetts, United States
Recorded site status: Not separately listed. Study location source ↗
New England Baptist Hospital
Boston, Massachusetts, United States
Recorded site status: Not separately listed. Study location source ↗
William Beaumont Hospital
Royal Oak, Michigan, United States
Recorded site status: Not separately listed. Study location source ↗
Mayo Clinic
Rochester, Minnesota, United States
Recorded site status: Not separately listed. Study location source ↗
WVU Medicine JW Ruby Memorial Hospital
Morgantown, West Virginia, United States
Recorded site status: Not separately listed. Study location source ↗
Related programs(2)
BiomX / former Adaptive Phage Therapeutics (PhageBank)
Historical/inactive
Recorded program–study link. Website
University of Maryland School of Medicine — James Doub clinical research
Intake unconfirmed
Recorded program–study link. Website
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Study ID | nct05269134 |
|---|